Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68:1576–87.
Google Scholar
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–48.
Google Scholar
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977–1010.
Google Scholar
Chen X, Zhang D, Jiang F, Shen Y, Li X, Hu X, et al. Prognostic prediction using a stemness index-related signature in a cohort of gastric cancer. Front Mol Biosci. 2020;7:570702.
Google Scholar
Klejnot M, Falnikar A, Ulaganathan V, Cross RA, Baas PW, Kozielski F. The crystal structure and biochemical characterization of Kif15: a bifunctional molecular motor involved in bipolar spindle formation and neuronal development. Acta Crystallogr D Biol Crystallogr. 2014;70:123–33.
Google Scholar
Tao J, Sun G, Li Q, Zhi X, Li Z, He Z, et al. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis. J Cell Physiol. 2020;235:9388–98.
Google Scholar
Liu M, Nadar VC, Kozielski F, Kozlowska M, Yu W, Baas PWKinesin-12. a mitotic microtubule-associated motor protein, impacts axonal growth, navigation, and branching. J Neurosci. 2010;30:14896–906.
Google Scholar
Zhang D, Povysil G, Kobeissy PH, Li Q, Wang B, Amelotte M, et al. Rare and common variants in KIF15 contribute to genetic risk of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2022;206:56–69.
Google Scholar
Gao L, Zhang W, Zhang J, Liu J, Sun F, Liu H, et al. KIF15-mediated stabilization of AR and AR-V7 contributes to enzalutamide resistance in prostate cancer. Cancer Res. 2021;81:1026–39.
Google Scholar
Huang J, Sun X, Diao G, Li R, Guo J, Han J. KIF15 knockdown inhibits the development of endometrial cancer by suppressing epithelial-mesenchymal transition and stemness through Wnt/β-catenin signaling. Environ Toxicol. 2023;38:1824–34.
Google Scholar
Qiao Y, Chen J, Ma C, Liu Y, Li P, Wang Y, et al. Increased KIF15 expression predicts a poor prognosis in patients with lung adenocarcinoma. Cell Physiol Biochem. 2018;51:1–10.
Google Scholar
Quan G, Xu J, Wang J, Liu X, Xu J, Jiang J. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. Cell Death Dis. 2023;14:137.
Google Scholar
Wang Q, Han B, Huang W, Qi C, Liu F. Identification of KIF15 as a potential therapeutic target and prognostic factor for glioma. Oncol Rep. 2020;43:1035–44.
Google Scholar
Li Q, Qiu J, Yang H, Sun G, Hu Y, Zhu D, et al. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma. Cancer Lett. 2020;482:112–25.
Google Scholar
Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal. 2005;7:768–77.
Google Scholar
Ishii T, Warabi E, Yanagawa T. Novel roles of peroxiredoxins in inflammation, cancer and innate immunity. J Clin Biochem Nutr. 2012;50:91–105.
Google Scholar
Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, et al. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients. Oncol Rep. 2007;18:867–71.
Google Scholar
Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer. J Urol. 2006;175:1512–6.
Google Scholar
Shen Y, You Z, Li L, Tang X, Shan X. The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis. Int J Cancer. 2024;155:1290–302.
Google Scholar
Xu H, Zhao H, Ding C, Jiang D, Zhao Z, Li Y, et al. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduct Target Ther. 2023;8:51.
Google Scholar
Zhang Z, Zhou P, Liu M, Pei B. Expression and prognostic role of PRDX1 in gastrointestinal cancers. J Cancer. 2023;14:2895–907.
Google Scholar
Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R, et al. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 2009;28:1505–17.
Google Scholar
Gong F, Hou G, Liu H, Zhang M. Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma. Med Oncol. 2015;32:455.
Google Scholar
Park MH, Jo M, Kim YR, Lee CK, Hong JT. Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases. Pharmacol Ther. 2016;163:1–23.
Google Scholar
Smith S. Telomerase can’t handle the stress. Genes Dev. 2018;32:597–9.
Google Scholar
Lee JS, See RH, Galvin KM, Wang J, Shi Y. Functional interactions between YY1 and adenovirus E1A. Nucleic Acids Res. 1995;23:925–31.
Google Scholar
Meliala ITS, Hosea R, Kasim V, Wu S. The biological implications of Yin Yang 1 in the hallmarks of cancer. Theranostics. 2020;10:4183–200.
Google Scholar
Górecki A, Bonarek P, Górka AK, Figiel M, Wilamowski M, Dziedzicka-Wasylewska M. Intrinsic disorder of human Yin Yang 1 protein. Proteins. 2015;83:1284–96.
Google Scholar
Sarvagalla S, Kolapalli SP, Vallabhapurapu S. The two sides of YY1 in cancer: a friend and a foe. Front Oncol. 2019;9:1230.
Google Scholar
Luo J, Jiang X, Cao L, Dai K, Zhang S, Ge X, et al. Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas. Onco Targets Ther. 2014;7:1753–9.
Google Scholar
Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, et al. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene. 2013;32:5078–88.
Google Scholar
Zhang JJ, Zhu Y, Zhang XF, Liu DF, Wang Y, Yang C, et al. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis. Cancer Lett. 2017;408:144–54.
Google Scholar
Li M, Liu Y, Wei Y, Wu C, Meng H, Niu W, et al. Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated microRNA-141 transcription. J Biol Chem. 2019;294:6172–87.
Google Scholar
Geng ZH, Du JX, Chen YD, Fu PY, Zhou PH, Qin WZ, et al. YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance. Cancer Cell Int. 2024;24:71.
Google Scholar
Kaufhold S, Garbán H, Bonavida B. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res. 2016;35:84.
Google Scholar
Morales-Martinez M, Valencia-Hipolito A, Vega GG, Neri N, Nambo MJ, Alvarado I, et al. Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma. Oncotarget. 2019;10:2173–88.
Google Scholar
Shah A, Dobrovolskaia MA. Detection of Changes in Mitochondrial Membrane Potential in T-cells Using JC-1 Dye: Version 1. National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols. Bethesda (MD): National Cancer Institute (US); 2005.
Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, et al. Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol. 2020;11:1280.
Google Scholar
Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311–22.
Google Scholar
Ding C, Fan X, Wu G. Peroxiredoxin 1 – an antioxidant enzyme in cancer. J Cell Mol Med. 2017;21:193–202.
Google Scholar
Son YW, Cheon MG, Kim Y, Jang HH. Prx2 links ROS homeostasis to stemness of cancer stem cells. Free Radic Biol Med. 2019;134:260–7.
Google Scholar
Wang J, Wu X, Dai W, Li J, Xiang L, Tang W, et al. The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer. Cancer Lett. 2020;482:90–101.
Google Scholar
Lu Y, Meng Q, Bai L, Wang R, Sun Y, Li J, et al. LINC00858 stabilizes RAN expression and promotes metastasis of gastric cancer. Biol Direct. 2022;17:41.
Google Scholar
Kang W, Tong JH, Chan AW, Zhao J, Dong Y, Wang S, et al. Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. J Transl Med. 2014;12:80.
Google Scholar
Sancho P, Barneda D, Heeschen C. Hallmarks of cancer stem cell metabolism. Br J Cancer. 2016;114:1305–12.
Google Scholar
Takaishi S, Okumura T, Wang TC. Gastric cancer stem cells. J Clin Oncol. 2008;26:2876–82.
Google Scholar
Qiu HL, Deng SZ, Li C, Tian ZN, Song XQ, Yao GD, et al. High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 2017;21:239–45.
Google Scholar
Milic B, Chakraborty A, Han K, Bassik MC, Block SM. KIF15 nanomechanics and kinesin inhibitors, with implications for cancer chemotherapeutics. Proc Natl Acad Sci USA. 2018;115:E4613–e22.
Google Scholar
Sebastian J. Dihydropyrazole and dihydropyrrole structures based design of Kif15 inhibitors as novel therapeutic agents for cancer. Comput Biol Chem. 2017;68:164–74.
Google Scholar
Zhou J, Dong S, Shi C. Identification of key pathways and biomarkers in anaplastic thyroid cancer using an integrated analysis. J bUON. 2020;25:2690–9.
Google Scholar
Terribas E, Fernández M, Mazuelas H, Fernández-Rodríguez J, Biayna J, Blanco I, et al. KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. Neurooncol Adv. 2020;2:i62–i74.
Google Scholar
Kitagawa A, Masuda T, Takahashi J, Tobo T, Noda M, Kuroda Y, et al. KIF15 expression in tumor-associated monocytes is a prognostic biomarker in hepatocellular carcinoma. Cancer Genomics Proteomics. 2020;17:141–9.
Google Scholar
Ding L, Li B, Yu X, Li Z, Li X, Dang S, et al. KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis. Cancer Cell Int. 2020;20:125.
Google Scholar
Zhao H, Bo Q, Wu Z, Liu Q, Li Y, Zhang N, et al. KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway. Cancer Manag Res. 2019;11:1857–68.
Google Scholar
Sun X, Chen M, Liao B, Liang Z. Knockdown of KIF15 promotes cell apoptosis by activating crosstalk of multiple pathways in ovarian cancer: bioinformatic and experimental analysis. Int J Clin Exp Pathol. 2021;14:267–91.
Google Scholar
Zeng H, Li T, Zhai D, Bi J, Kuang X, Lu S, et al. ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. Int J Biol Sci. 2020;16:2084–93.
Google Scholar
Ma Y, Zhan S, Lu H, Wang R, Xu Y, Zhang G, et al. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer. Cell Death Dis. 2020;11:824.
Google Scholar
Gao X, Zhu L, Lu X, Wang Y, Li R, Jiang G. KIF15 contributes to cell proliferation and migration in breast cancer. Hum Cell. 2020;33:1218–28.
Google Scholar
Wang Z, Chen M, Fang X, Hong H, Yao Y, Huang H. KIF15 is involved in development and progression of Burkitt lymphoma. Cancer Cell Int. 2021;21:261.
Google Scholar
Qureshi Z, Ahmad M, Yang WX, Tan FQ. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer. Biochem Biophys Res Commun. 2021;576:7–14.
Google Scholar
Sun QK, Zhu JY, Wang W, Lv Y, Zhou HC, Yu JH, et al. Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. Med Oncol. 2014;31:786.
Google Scholar
Gong F, Liu H, Li J, Xue L, Zhang M. Peroxiredoxin 1 is involved in disassembly of flagella and cilia. Biochem Biophys Res Commun. 2014;444:420–6.
Google Scholar
Taniuchi K, Furihata M, Hanazaki K, Iwasaki S, Tanaka K, Shimizu T, et al. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity. Pancreas. 2015;44:331–40.
Google Scholar
Gao J, Gao G, Zhang Y, Wang F. Proteomic analysis of human epithelial ovarian cancer xenografts in immunodeficient mice exposed to chronic psychological stress. Sci China Life Sci. 2011;54:112–20.
Google Scholar
Li S, Wang R, Zhang M, Wang L, Cheng S. Proteomic analysis of non-small cell lung cancer tissue interstitial fluids. World J Surg Oncol. 2013;11:173.
Google Scholar
Turner-Ivey B, Manevich Y, Schulte J, Kistner-Griffin E, Jezierska-Drutel A, Liu Y, et al. Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer. Oncogene. 2013;32:5302–14.
Google Scholar
Wang J, Lin D, Peng H, Huang Y, Huang J, Gu J. Cancer-derived immunoglobulin G promotes tumor cell growth and proliferation through inducing production of reactive oxygen species. Cell Death Dis. 2013;4:e945.
Google Scholar
Zhou W, Feng Y, Lin C, Chao CK, He Z, Zhao S, et al. Yin Yang 1-induced long noncoding RNA DUXAP9 drives the progression of oral squamous cell carcinoma by blocking CDK1-mediated EZH2 degradation. Adv Sci. 2023;10:e2207549.
Google Scholar
Yang P, Li J, Peng C, Tan Y, Chen R, Peng W, et al. TCONS_00012883 promotes proliferation and metastasis via DDX3/YY1/MMP1/PI3K-AKT axis in colorectal cancer. Clin Transl Med. 2020;10:e211.
Google Scholar
Han J, Meng J, Chen S, Wang X, Yin S, Zhang Q, et al. YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res. 2019;79:1451–64.
Google Scholar
Zhang C, Chen S, Wang W, Gao Y. YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR. Funct Integr Genomics. 2023;23:269.
Google Scholar
Zhang L, Zou L, Sun P. Relationship between miR-378c and YY1 expression in patients with gastric cancer and the clinicopathological features. Cell Mol Biol Lett. 2021;26:12.
Google Scholar
Zhang T, Beeharry MK, Wang Z, Zhu Z, Li J, Li C. YY1-modulated long non-coding RNA SNHG12 promotes gastric cancer metastasis by activating the miR-218-5p/YWHAZ axis. Int J Biol Sci. 2021;17:1629–43.
Google Scholar
Zheng JY, Zhu T, Zhuo W, Mao XY, Yin JY, Li X, et al. eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of β-catenin. Biochem Pharmacol. 2023;213:115616.
Google Scholar
